diphenylcyclopropenone has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holzer, AM; Leonard, LK; Levis, WR | 1 |
Levis, WR | 1 |
1 trial(s) available for diphenylcyclopropenone and HIV Coinfection
Article | Year |
---|---|
Topical diphenylcyclopropenone as a measure of immune competence in HIV-seropositive subjects.
Topics: Administration, Cutaneous; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclopropanes; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Patch Tests; Photosensitizing Agents; Predictive Value of Tests; Viral Load | 2006 |
1 other study(ies) available for diphenylcyclopropenone and HIV Coinfection
Article | Year |
---|---|
Evaluation of delayed-type hypersensitivity in patients with suspected immunodeficiency.
Topics: Cyclopropanes; Dermatitis, Allergic Contact; HIV Infections; Humans; Hypersensitivity, Delayed; Immunocompetence; Skin Tests | 2008 |